To our knowledge, this is the first time that a LOPAC® library was used in the context of a random screening against ALS-related SOD1 variants for the discovery of inhibitors/rescuers of aggregation that are directly targeted to SOD1 (protein–drug interaction). This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.